Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-08-04

Clinical Trial Update: Influence of OATP1B1 and CYP2C9 Genotypes on the Pharmacokinetics of Bosentan Before and During Clarithromycin

View source ↗

Summary

A completed pharmacokinetics study evaluating how OATP1B1 and CYP2C9 genotypes influence bosentan exposure before and during co-administration with clarithromyc…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Biaxin (clarithromycin)
  • TRACLEER (bosentan)

Snippet

Sponsor: Gerd Mikus | Conditions: Drug Interactions | Status: COMPLETED | Results posted: 2015-08-04